Therapeutic inhibition of inflammatory monocyte recruitment reduces steatohepatitis and liver fibrosis
Oliver Krenkel(Boehringer Ingelheim (Germany)), Frank Tacke(Charité - Universitätsmedizin Berlin), Anke Liepelt(Universitätsklinikum Aachen), Jana C. Mossanen(Universitätsklinikum Aachen), Olivier Govaere(VIB-KU Leuven Center for Microbiology), Marlene Kohlhepp(Charité - Universitätsmedizin Berlin), Thomas Longerich(Heidelberg University), Ali T. Abdallah, Ralf Weiskirchen(Universitätsklinikum Aachen), Ivan G. Costa(Max Planck Institute for Biology of Ageing), Quentin M. Anstee(Newcastle upon Tyne Hospital), Claus Hellerbrand(Friedrich-Alexander-Universität Erlangen-Nürnberg), Tobias Puengel(Charité - Universitätsmedizin Berlin), Tom Luedde(Düsseldorf University Hospital), Éric Lefebvre(Pinnacle Clinical Research), Christian Trautwein(TUM Klinikum)
Cited by 550
Related Papers
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Hepatology|2023|2.9k
A multisociety Delphi consensus statement on new fatty liver disease nomenclature
|Journal of Hepatology|2023|2.7k
EASL–EASD–EASO Clinical Practice Guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)
|Journal of Hepatology|2024|1.6k
Senescence surveillance of pre-malignant hepatocytes limits liver cancer development
|Nature|2011|1.6k
Deep learning can predict microsatellite instability directly from histology in gastrointestinal cancer
|Nature Medicine|2019|1.5k